Wednesday 21 June, 14:30 - 15:15
Bas van der Baan is an international business development executive, business leader and strong team builder who identifies and empowers team members with the required skill sets to be successful in turning complex innovative technologies into commercial success. Over 20 years experience in the biotechnology industry. Played a key role in financing activities with over $200 million raised. He co-founded Agendia Inc (US), developed, and sold a liquid biopsy molecular diagnostic company to market leader.
Bas is currently Chief Clinical Officer at Agendia, a venture partner at XGEN venture fund, holds board positions at Tethis (Italy) and Lixte (US). He graduated from Wageningen University with a Masters degree in Molecular Sciences.
Agendia is a mission-driven, commercial stage company focused on enabling optimized decision-making by providing physicians with next-generation diagnostic and information solutions that can be used to help improve outcomes for breast cancer patients worldwide. The company currently offers two commercially-available genomic profiling tests that help surgeons, oncologists and pathologists to personalize treatment for women at critical intervention points throughout their patient journey.
Powered by: BCF Courses BV | Connect with us | Join BioBusiness Summer School | |||
Privacy Policy Terms & Conditions Chamber of Commerce: 75874415 | | REGISTER NOW |
© Copyright 2020 by BCF Courses